The NCI Women Scientist Advisors Committee hosted a career development luncheon January 12 at the annual NCI Intramural Scientific Investigators Retreat. The NCI Women Scientist Advisors are composed of representatives from NCI’s two internal (intramural) research groups, the Center for Cancer Research (CCR) and Division of Cancer Epidemiology and Genetics (DCEG). Representatives from DCEG, Drs. Katherine McGlynn and Mary Ward, talked with the NCI Cancer Bulletin about the Women Scientist Advisors’ role at NCI. CCR’s representatives are Drs. Ying Zhang, Brigitte Widemann, and Cheryl Ann Winkler.
NCI Cancer Bulletin
In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB â�¨declared: â�¨”As a leader in epilepsy UCB has a responsibility to develop effective medicines that address unmet medical needs…
Health News from Medical News Today
The scandal of the faulty, badly made breast implants from French company Poly Implant Prothese (PIP) continues with the arrest of Jean-Claude Mas, 72, who according to police has been held at his home in Six-Fours-les-Plages in the South of France. Up to 400,000 thousand women are believed to have been given the implants and the problem extends across some 65 countries, with England and France amongst others assuring those involved that the public health system will cover the cost of removing or replacing the implants…
Health News from Medical News Today
ABC News |
Avastin Before Breast Cancer Surgery Could Help Save Lives
ABC News
Taking Avastin before breast cancer surgery could significantly shrink tumors and reduce the chance of recurrence in women with less common but more aggressive forms of breast cancer, according to two new studies. The US Food and Drug Administration …
Avastin fights early breast cancer in 2 studiesCBS News
Studies: Avastin may fight early breast cancersFox News
Breast Cancer Survival – Why Avastin And Sutent Don't HelpMedical News Today
Detroit Free Press -FiercePharma -abc7.com
all 188 news articles »
|
cancer – Google News
Los Angeles Times |
Breast cancer drugs' effectiveness doubted by UM study
Detroit Free Press
By Robin Erb Two drugs used to treat metastatic breast cancer increased the number of cancer stem cells in tumors in mice — possibly explaining why, after promising initial results, the drugs may not extend human lives after all, according to new …
Avastin Before Breast Cancer Surgery Could Help Save LivesABC News
Studies: Avastin may fight early breast cancersAlbany Times Union
Studies suggest Avastin may fight early breast cancer; drug lost OK in US for …Washington Post
Los Angeles Times -WebMD
all 173 news articles »
|
cancer – Google News
NEW YORK (Reuters Health) – People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer — years after the arsenic problem was brought under …
cancer – Bing News
According to survey by GlaxoSmithKline (GSK), individuals aged 55+ are more active than the younger generation. Results from the survey revealed that people over the age of 55 do around 28 minutes more physical activity per week than their 18 to 25 year-old counterparts. Although there is clear evidence of the health benefits associated with physical activity, 30% of survey respondents over the age of 55 cite the British weather as the most restricting factor for engaging in physical activity, followed by long term health conditions (29%). In order to motivate the 7…
Health News from Medical News Today
(CBS) A drug that is commonly used to treat men with enlarged prostates may also delay the growth of prostate cancer, according to a new study. The drug, dutasteride, works by blocking the conversion of testosterone to dihydrotestosterone, the …
cancer – Bing News
Essential Series: LymphomaEssential Series: Lymphoma A collection of selected reports – All You Need to Know About Lymphoma Asking Your Doctor about Lympho…
Among women with invasive epithelial ovarian cancer, patients having a germline (gene change in a reproductive cell that could be passed to offspring) mutation in the BRCA1 or BRCA2 genes was associated with improved five-year overall survival, with BRCA2 carriers having the best prognosis, according to a new study.
ScienceDaily: Cancer News
Categories:
Lymphoblastic Cancer Caregiver Tags:
BRCA, Cancer, Certain, Gene, Improved, Mutation, Ovarian, survival, Type, Women, Years
